3M CO Interest Expense
3M CO (MMM) reported Interest Expense of $322.00 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-07-26.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-07-26
- 3M CO interest expense for the quarter ending 2024-06-30 was $322.00M, a 123.61% increase year-over-year.
- 3M CO interest expense for the quarter ending 2024-03-31 was $385.00M, a 213.01% increase year-over-year.
- 3M CO interest expense for the quarter ending 2023-12-31 was $371.00M, a 222.61% increase year-over-year.
- 3M CO interest expense for the quarter ending 2023-09-30 was $304.00M, a 186.79% increase year-over-year.
- 3M CO interest expense for fiscal 2023 was $942.00M, a 103.90% increase from fiscal 2022.
- 3M CO interest expense for fiscal 2022 was $462.00M, a 5.33% decline from fiscal 2021.
- 3M CO interest expense for fiscal 2021 was $488.00M, a 7.75% decline from fiscal 2020.
- 3M CO interest expense for fiscal 2020 was $529.00M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $322.00M 10-Q · filed 2024-07-26 | $663.00M 10-Q · filed 2024-07-26 | $1.08B derived: sum of 3 quarters · filed 2024-07-26 | $1.38B derived: sum of 4 quarters · filed 2024-07-26 |
| 2024-03-31 | $385.00M 10-Q · filed 2024-04-30 | $756.00M derived: sum of 2 quarters · filed 2024-04-30 | $1.06B derived: sum of 3 quarters · filed 2024-04-30 | $1.20B derived: sum of 4 quarters · filed 2024-07-26 |
| 2023-12-31 | $371.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $675.00M derived: sum of 2 quarters · filed 2024-02-07 | $819.00M derived: sum of 3 quarters · filed 2024-07-26 | $942.00M 10-K · filed 2024-02-07 |
| 2023-09-30 | $304.00M 10-Q · filed 2023-10-24 | $448.00M derived: sum of 2 quarters · filed 2024-07-26 | $571.00M 10-Q · filed 2023-10-24 | $686.00M derived: sum of 4 quarters · filed 2024-07-26 |
| 2023-06-30 | $144.00M 10-Q · filed 2024-07-26 | $267.00M 10-Q · filed 2024-07-26 | $382.00M derived: sum of 3 quarters · filed 2024-07-26 | $488.00M derived: sum of 4 quarters · filed 2024-07-26 |
| 2023-03-31 | $123.00M 10-Q · filed 2024-04-30 | $238.00M derived: sum of 2 quarters · filed 2024-04-30 | $344.00M derived: sum of 3 quarters · filed 2024-04-30 | $472.00M derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $115.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $221.00M derived: sum of 2 quarters · filed 2024-02-07 | $349.00M derived: sum of 3 quarters · filed 2024-02-07 | $462.00M 10-K · filed 2024-02-07 |
| 2022-09-30 | $106.00M 10-Q · filed 2023-10-24 | $234.00M derived: sum of 2 quarters · filed 2023-10-24 | $347.00M 10-Q · filed 2023-10-24 | $465.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $128.00M 10-Q · filed 2023-07-25 | $241.00M 10-Q · filed 2023-07-25 | $359.00M derived: sum of 3 quarters · filed 2024-02-07 | $476.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $113.00M 10-Q · filed 2023-04-25 | $231.00M derived: sum of 2 quarters · filed 2024-02-07 | $348.00M derived: sum of 3 quarters · filed 2024-02-07 | $469.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $118.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $235.00M derived: sum of 2 quarters · filed 2024-02-07 | $356.00M derived: sum of 3 quarters · filed 2024-02-07 | $488.00M 10-K · filed 2024-02-07 |
| 2021-09-30 | $117.00M 10-Q · filed 2022-10-25 | $238.00M derived: sum of 2 quarters · filed 2022-10-25 | $370.00M 10-Q · filed 2022-10-25 | $511.00M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-06-30 | $121.00M 10-Q · filed 2022-07-27 | $253.00M 10-Q · filed 2022-07-27 | $394.00M derived: sum of 3 quarters · filed 2023-02-08 | $522.00M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-03-31 | $132.00M 10-Q · filed 2022-04-26 | $273.00M derived: sum of 2 quarters · filed 2023-02-08 | $401.00M derived: sum of 3 quarters · filed 2023-02-08 | $538.00M derived: sum of 4 quarters · filed 2023-02-08 |
| 2020-12-31 | $141.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $269.00M derived: sum of 2 quarters · filed 2023-02-08 | $406.00M derived: sum of 3 quarters · filed 2023-02-08 | $529.00M 10-K · filed 2023-02-08 |
| 2020-09-30 | $128.00M 10-Q · filed 2021-10-26 | $265.00M derived: sum of 2 quarters · filed 2021-10-26 | $388.00M 10-Q · filed 2021-10-26 | $512.00M derived: sum of 4 quarters · filed 2022-04-26 |
| 2020-06-30 | $137.00M 10-Q · filed 2021-07-27 | $260.00M 10-Q · filed 2021-07-27 | $384.00M derived: sum of 3 quarters · filed 2022-04-26 | $493.00M derived: sum of 4 quarters · filed 2022-04-26 |
| 2020-03-31 | $123.00M 10-Q · filed 2021-04-27 | $247.00M derived: sum of 2 quarters · filed 2022-04-26 | $356.00M derived: sum of 3 quarters · filed 2022-04-26 | $467.00M derived: sum of 4 quarters · filed 2022-04-26 |
| 2019-12-31 | $124.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-04-26 | $233.00M derived: sum of 2 quarters · filed 2022-04-26 | $344.00M derived: sum of 3 quarters · filed 2022-04-26 | $448.00M 8-K · filed 2022-04-26 |
| 2019-09-30 | $109.00M 10-Q · filed 2020-10-27 | $220.00M derived: sum of 2 quarters · filed 2020-10-27 | $324.00M 10-Q · filed 2020-10-27 | $419.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-06-30 | $111.00M 10-Q · filed 2020-07-28 | $215.00M 10-Q · filed 2020-07-28 | $310.00M derived: sum of 3 quarters · filed 2021-02-04 | $395.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-03-31 | $104.00M 10-Q · filed 2020-04-28 | $199.00M derived: sum of 2 quarters · filed 2021-02-04 | $284.00M derived: sum of 3 quarters · filed 2021-02-04 | $372.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2018-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $180.00M derived: sum of 2 quarters · filed 2021-02-04 | $268.00M derived: sum of 3 quarters · filed 2021-02-04 | $350.00M 10-K · filed 2021-02-04 |
| 2018-09-30 | $85.00M 10-Q · filed 2019-10-25 | $173.00M derived: sum of 2 quarters · filed 2019-10-25 | $255.00M 10-Q · filed 2019-10-25 | $421.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $88.00M 10-Q · filed 2019-07-26 | $170.00M 10-Q · filed 2019-07-26 | $336.00M derived: sum of 3 quarters · filed 2020-02-06 | $393.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $82.00M 10-Q · filed 2019-04-26 | $248.00M derived: sum of 2 quarters · filed 2020-02-06 | $305.00M derived: sum of 3 quarters · filed 2020-02-06 | $359.00M derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $166.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $223.00M derived: sum of 2 quarters · filed 2020-02-06 | $277.00M derived: sum of 3 quarters · filed 2020-02-06 | $322.00M 10-K · filed 2020-02-06 |
| 2017-09-30 | $57.00M 10-Q · filed 2018-10-25 | $111.00M derived: sum of 2 quarters · filed 2018-10-25 | $156.00M 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $54.00M 10-Q · filed 2018-07-26 | $99.00M 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | $45.00M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $199.00M 10-K · filed 2019-02-07 | |||
| 2015-12-31 | $149.00M 8-K · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |